… A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells
immunotherapy after radical resection of hepatocellular carcinoma. Digestive and liver disease Offic …

… hepatocellular carcinoma. Conclusions: This retrospective study in our hospital showed …
adjuvant immunotherapy with cytokine-induced killer (CIK) cells for HCC patients as an adjuvant …

… Cytokine-induced killer (CIK) cells refer to cytotoxic lymphocytes obtained by in vitro co-…
Adjuvant cytokineinduced killer cell immunotherapy for hepatocellular carcinoma: a propensity …

… Besides the 63 studies that adopted CIK cell therapy as an adjuvant … -CIK cells in combination
with a PD-1 blockade pembrolizumab in hepatocellular carcinoma, renal cell carcinoma …

… adjuvant cytokine-induced killer (CIK) cell immunotherapy after curative treatment for
hepatocellular carcinoma (… CIK cell immunotherapy as an adjuvant therapy for HCC compared to …

… A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells
immunotherapy after radical resection of hepatocellular carcinoma. Digestive and liver disease: …

… -stage hepatocellular carcinoma (HCC) is inoperable and currently has no form of adjuvant
… (GCJ) combined with cytokine-induced killer (CIK)-cell-based immunotherapy as a palliative …

… ), natural killer (NK) cells, cytokine-induced killer (CIK) cells, … of adoptive immunotherapy
in hepatocellular carcinoma. It … CIK cell therapy was recommended as an adjuvant treatment …

… The authors performed a retrospective study to investigate the impact of cytokine-induced
killer (CIK) cell immunotherapy on the long-term survival of patients with stage I–II NSCLC after …

… Moreover, studies based on NK cell infusion are completed (Table 1), even if data are not …
which adjuvant immunotherapy with activated autologous Cytokine-induced killer (CIK) cells in …